Amgen, Novartis, PhRMA, Alzheimer’s: Readout Newsletter
Need to keep on high of the science and politics driving biotech immediately? Join to get our biotech e-newsletter in your inbox. ...
Need to keep on high of the science and politics driving biotech immediately? Join to get our biotech e-newsletter in your inbox. ...
Ed’s tales discover prescription drug pricing, affordability and entry, as properly points surrounding patents, litigation, and laws. He's additionally the ...
Allison covers what sizzling startups are getting as much as, and who’s financing them. She can be co-host of the ...
With the merger, Processa’s new lead asset is a Vidya Therapeutics immunology drug that provides pipeline-in-a-product potential addressing a goal ...
Myricx Bio brings to Novartis antibody drug conjugates with a novel cancer-killing payload referred to as an NMT inhibitor. Novartis ...
Wish to keep on prime of the science and politics driving biotech at the moment? Join to get our biotech e-newsletter in ...
Merck has been buying belongings that might assist make up for the approaching income decline as its high product, the ...
Novartis has settled a lawsuit by the property of Henrietta Lacks that alleged the pharmaceutical large unjustly profited off her ...
Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45.LONDON — ...
Drugs for the rare hormone disorder acromegaly include older engineered peptides administered as frequent injections. A new FDA approval brings ...
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.
Copyright © 2025 Your Health 24 7.
Your Health 24 7 is not responsible for the content of external sites.